Skip to main content
SpringerLink
Log in

Que fait-on en Europe? Le point de vue du Groupe européen en pathologie mammaire (EWGBP)

European breast expert pathologists experience in vacuum assisted core needle biopsies for “B3” lesions according to the European guidelines: 30 questions

  • Conference paper
Cancer du sein : surdiagnostic, surtraitement

  • 230 Accesses

Résumé

Les campagnes de dépistage ont entraîné un développement considérable de la pratique des microbiopsies afin de réduire les interventions inutiles. Pour faciliter le dialogue pluridisciplinaire, les recommandations européennes ont établi de classer ces lésions en « B » sur un mode superposable à celui de la classification ACR. Les lésions franchement bénignes sont classées en B2 et les malignes en B5. La catégorie B3 correspond à un groupe hétérogène de lésions à risque d’être associées à un cancer en bordure ou à un risque ultérieur de développer un cancer. Les auteurs ont déclaré n’avoir aucun lien d’intérêt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Rakha EA, Ho BC, Naik V et al. (2011) Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia. Histopathology 58: 626–632

    Article  PubMed  Google Scholar 

  2. Lavoue V, Roger CM, Poilblanc M et al. (2011) Pure flat epithelial atypia (DIN 1a) on core needle biopsy: study of 60 biopsies with follow-up surgical excision. Breast Cancer Res Treat 125: 121–126

    Article  PubMed  Google Scholar 

  3. Forgeard C, Benchaib M, Guerin N et al. (2008) Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg 196: 339–345

    Article  PubMed  Google Scholar 

  4. Bianchi S, Caini S, Renne G et al. (2011) Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy. Breast 20: 264–270

    Article  PubMed  CAS  Google Scholar 

  5. Londero V, Zuiani C, Linda A, Battigelli L, Brondani G, Bazzocchi M (2011) Borderline breast lesions: comparison of malignancy underestimation rates with 14-gauge core needle biopsy versus 11-gauge vacuum-assisted device. Eur Radiol 21: 1200–1206

    Article  PubMed  Google Scholar 

  6. Reefy S, Osman H, Chao C, Perry N, Mokbel K (2010) Surgical excision for B3 breast lesions diagnosed by vacuum-assisted core biopsy. Anticancer Res 30: 2287–2290

    PubMed  CAS  Google Scholar 

  7. Zito FA, Verderio P, Simone G et al. (2010) Reproducibility in the diagnosis of needle core biopsies of non-palpable breast lesions: an international study using virtual slides published on the world-wide web. Histopathology 56: 720–726

    Article  PubMed  Google Scholar 

  8. Tennant SL, Evans A, Hamilton LJ et al. (2008) Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) — an alternative to surgery in selected cases. Breast 17: 546–549

    Article  PubMed  CAS  Google Scholar 

  9. Carder PJ, Khan T, Burrows P, Sharma N (2008) Large volume “mammotome” biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast. J Clin Pathol 61: 928–933

    Article  PubMed  CAS  Google Scholar 

  10. Hayes BD, O’Doherty A, Quinn CM (2009) Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience. J Clin Pathol 62: 1136–1140

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de biopathologie et d’oncologie moléculaire, Centre de Recherche en Cancérologie de Marseille Institut Paoli-Calmettes-UMR891, Inserm-Université de la Méditerranée, 232, boulevard de Sainte-Marguerite, 13009, Marseille

    J. Jacquemier

  2. Département de pathologie, CHU Avenue Molière, 67098, Strasbourg

    J. -P. Bellocq

Authors
  1. J. Jacquemier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. -P. Bellocq
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this paper

Cite this paper

Jacquemier, J., Bellocq, J.P. (2012). Que fait-on en Europe? Le point de vue du Groupe européen en pathologie mammaire (EWGBP). In: Cancer du sein : surdiagnostic, surtraitement. Springer, Paris. https://doi.org/10.1007/978-2-8178-0249-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0249-7_12

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0248-0

  • Online ISBN: 978-2-8178-0249-7

Publish with us

Policies and ethics

Search

Navigation